Ksenia Sukhova

Ksenia Sukhova

Auto-generated profile, based on publicly available information

Ksenia Sukhova

Imperial College London

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
TPThomas Peacock
Thomas Peacock
LMLouise Moncla
Louise Moncla
GDGytis Dudas
Gytis Dudas
DVDavid VanInsberghe
David VanInsberghe
KSKsenia Sukhova
Ksenia Sukhova
MNMartha I. Nelson
Martha I. Nelson
Influenza A viruses (IAV) have caused more documented global pandemics in human history than any other pathogen1,2. High pathogenicity avian influenza (HPAI) viruses belonging to the H5N1 subtype are a leading pandemic risk. Two decades after H5N1 “bird flu” became established in poultry in Southeast Asia, its descendants have resurged3, setting off an H5N1 panzootic in wild birds that is fueled by (a) rapid intercontinental spread, reaching South America and Antarctica for the first time4,5; (b) fast evolution via genomic reassortment6; and (c) frequent spillover into terrestrial7,8 and marine mammals9. The virus has sustained mammal-to-mammal transmission in multiple settings, including European fur farms10,11, South American marine mammals12–15, and US dairy cattle16–19, raising questions about whether humans are next. Historically, swine are considered optimal intermediary hosts that help avian influenza viruses (AIV) adapt to mammals before jumping to humans20. However, the altered ecology of H5N1 has opened the door to new evolutionary pathways. Could dairy cattle, farmed mink, or South American sea lions serve as new mammalian gateways to humans? Here we explore the molecular and ecological factors driving H5N1’s sudden expansion in host range and assess the likelihood of different zoonotic pathways leading to an H5N1 pandemic.

3 January 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
TPThomas Peacock
Thomas Peacock
JBJonathan C. Brown
Jonathan C. Brown
JZJie Zhou
Jie Zhou
NTNazia Thakur
Nazia Thakur
KSKsenia Sukhova
Ksenia Sukhova
WBWendy S. Barclay
Wendy S. Barclay
The SARS-CoV-2 Omicron/BA.1 lineage emerged in late 2021 and rapidly displaced the Delta variant before being overtaken itself globally by, the Omicron/BA.2 lineage in early 2022. Here, we describe how Omicron BA.1 and BA.2 show a lower severity phenotype in a hamster model of pathogenicity which maps specifically to the spike gene. We further show that Omicron is attenuated in a lung cell line but replicates more rapidly, albeit to lower peak titres, in human primary nasal cells. This replication phenotype also maps to the spike gene. Omicron spike (including the emerging Omicron lineage BA.4) shows attenuated fusogenicity and a preference for cell entry via the endosomal route. We map the altered Omicron spike entry route and partially map the lower fusogenicity to the S2 domain, particularly the substitution N969K. Finally, we show that pseudovirus with Omicron spike, engineered in the S2 domain to confer a more Delta-like cell entry route retains the antigenic properties of Omicron. This shows a distinct separation between the genetic determinants of these two key Omicron phenotypes, raising the concerning possibility that future variants with large antigenic distance from currently circulating and vaccine strains will not necessarily display the lower intrinsic severity seen during Omicron infection.

10 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AIAlewo Idoko-Akoh
Alewo Idoko-Akoh
DGDaniel H. Goldhill
Daniel H. Goldhill
CSCarol M. Sheppard
Carol M. Sheppard
DBDagmara Bialy
Dagmara Bialy
JQJessica L. Quantrill
Jessica L. Quantrill
MMMike J. McGrew
Mike J. McGrew
Chickens genetically resistant to avian influenza could prevent future outbreaks. In chickens, influenza A virus (IAV) relies on host protein ANP32A. Here we use CRISPR/Cas9 to generate homozygous gene edited (GE) chickens containing two ANP32A amino acid substitutions that prevent viral polymerase interaction. After IAV challenge, 9/10 edited chickens remain uninfected. Challenge with a higher dose, however, led to breakthrough infections. Breakthrough IAV virus contained IAV polymerase gene mutations that conferred adaptation to the edited chicken ANP32A. Unexpectedly, this virus also replicated in chicken embryos edited to remove the entire ANP32A gene and instead co-opted alternative ANP32 protein family members, chicken ANP32B and ANP32E. Additional genome editing for removal of ANP32B and ANP32E eliminated all viral growth in chicken cells. Our data illustrate a first proof of concept step to generate IAV-resistant chickens and show that multiple genetic modifications will be required to curtail viral escape.

10 October 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
CSCarol M. Sheppard
Carol M. Sheppard
DGDaniel H. Goldhill
Daniel H. Goldhill
OSOlivia C. Swann
Olivia C. Swann
ESEcco Staller
Ecco Staller
RPRebecca Penn
Rebecca Penn
WBWendy S. Barclay
Wendy S. Barclay
Human ANP32A and ANP32B are essential but redundant host factors for influenza virus genome replication. While most influenza viruses cannot replicate in edited human cells lacking both ANP32A and ANP32B, some strains exhibit limited growth. Here, we experimentally evolve such an influenza A virus in these edited cells and unexpectedly, after 2 passages, we observe robust viral growth. We find two mutations in different subunits of the influenza polymerase that enable the mutant virus to use a novel host factor, ANP32E, an alternative family member, which is unable to support the wild type polymerase. Both mutations reside in the symmetric dimer interface between two polymerase complexes and reduce polymerase dimerization. These mutations have previously been identified as adapting influenza viruses to mice. Indeed, the evolved virus gains the ability to use suboptimal mouse ANP32 proteins and becomes more virulent in mice. We identify further mutations in the symmetric dimer interface which we predict allow influenza to adapt to use suboptimal ANP32 proteins through a similar mechanism. Overall, our results suggest a balance between asymmetric and symmetric dimers of influenza virus polymerase that is influenced by the interaction between polymerase and ANP32 host proteins.

27 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
CTCedric C. S. Tan
Cedric C. S. Tan
JTJahcub Trew
Jahcub Trew
TPThomas Peacock
Thomas Peacock
KMKai Yi Mok
Kai Yi Mok
CHCharlie Hart
Charlie Hart
VSVincent Savolainen
Vincent Savolainen
There has been limited characterisation of bat-borne coronaviruses in Europe. Here, we screened for coronaviruses in 48 faecal samples from 16 of the 17 bat species breeding in the UK, collected through a bat rehabilitation and conservationist network. We recovered nine complete genomes, including two novel coronavirus species, across six bat species: four alphacoronaviruses, a MERS-related betacoronavirus, and four closely related sarbecoviruses. We demonstrate that at least one of these sarbecoviruses can bind and use the human ACE2 receptor for infecting human cells, albeit suboptimally. Additionally, the spike proteins of these sarbecoviruses possess an R-A-K-Q motif, which lies only one nucleotide mutation away from a furin cleavage site (FCS) that enhances infectivity in other coronaviruses, including SARS-CoV-2. However, mutating this motif to an FCS does not enable spike cleavage. Overall, while UK sarbecoviruses would require further molecular adaptations to infect humans, their zoonotic risk warrants closer surveillance.

9 August 2023 in Journal of The Royal Society Interface
Verified
Journal Article
Open access
CMClare P. McCormack
Clare P. McCormack
AYAda W. C. Yan
Ada W. C. Yan
JBJonathan C. Brown
Jonathan C. Brown
KSKsenia Sukhova
Ksenia Sukhova
TPThomas Peacock
Thomas Peacock
IDIlaria Dorigatti
Ilaria Dorigatti
We use viral kinetic models fitted to viral load data from in vitro studies to explain why the SARS-CoV-2 Omicron variant replicates faster than the Delta variant in nasal cells, but slower than Delta in lung cells, which could explain Omicron's higher transmission potential and lower severity. We find that in both nasal and lung cells, viral infectivity is higher for Omicron but the virus production rate is higher for Delta, with an estimated approximately 200-fold increase in infectivity and 100-fold decrease in virus production when comparing Omicron with Delta in nasal cells. However, the differences are unequal between cell types, and ultimately lead to the basic reproduction number and growth rate being higher for Omicron in nasal cells, and higher for Delta in lung cells. In nasal cells, Omicron alone can enter via a TMPRSS2-independent pathway, but it is primarily increased efficiency of TMPRSS2-dependent entry which accounts for Omicron's increased activity. This work paves the way for using within-host mathematical models to understand the transmission potential and severity of future variants.